Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases / edited by Richard K. Burt, Dominique Farge, Milton A. Ruiz, Riccardo Saccardi, John A. Snowden.

Format:

Book

Contributor:

Burt, Richard K., 1956- editor.

Farge, Dominique, editor.

Ruiz, Milton A., editor.

Saccardi, Riccardo, editor.

Snowden, John A., editor.

Taylor & Francis eBooks.

William Pepper Medical Library Fund.

Language:

English

Subjects (All):

Autoimmune diseases--Treatment.

Autoimmune diseases.

Hematopoietic stem cells--Transplantation.

Hematopoietic stem cells.

Cellular therapy.

Physical Description:

1 online resource (1 volume) : illustrations (black and white, and colour)

polychrome

Place of Publication:

Boca Raton : CRC Press, 2021.

System Details:

text file

Biography/History:

Richard K. Burt, MD (www.astemcelljourney.com) is Fulbright Scholar and Professor of Medicine at Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA, and the first Autoimmune Committee Chairperson for the International Bone Marrow Transplant Registry (IBMTR). Dominique Farge, MD, PhD is Professor of Internal Medicine at Saint-Louis Hospital, Assistance Publique-H̥pitaux de Paris, (AP-HP), University of Paris, Paris, France; Adjunct Professor at McGill University, Montreal, Canada; and Chairperson of the EuropeanSociety for Blood and Marrow Transplantation Autoimmune Disease Working Party from 2010 to 2016. Milton A. Ruiz, MD, PhD is former Professor at the University of Sô Paulo and the head coordinator of the Hematopoietic Stem Cell Transplant Service of the Beneficn̊cia Portuguesa Hospital of Sô Još do Rio Preto, Sô Paulo, Brazil. Riccardo Saccardi, MD is Director of Cellular Therapies and Transfusion Medicine Department at Careggi University Hospital in Florence, Italy and Chairperson of the EuropeanSociety for Blood and Marrow Transplantation Autoimmune Disease Working Party from 2004 to 2010. John A. Snowden, MD is Consultant Haematologist & Director of Blood and Marrow Transplantation, Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; Honorary Professor, Department of Oncology & Metabolism, The University of Sheffield, Sheffield, UK; Honorary Clinical Professor, The Cancer Institute, Department of Haematology, University College London, UK; and Chairperson of the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party from 2016 to 2020.

Contents:

<P>able of Contents</P><P>Section 1- Biology of Immune Cells<BR>Ch 1 B cells in aging, age-associated diseases and stem cell transplantation<BR>Daniela Frasca, Maria Romero</P><P>Ch 2 T cell biology: changes with disease, aging, and hematopoietic stem cell transplantation<BR>Valquiria Bueno</P><P>Ch 3 Plasma cells in autoimmunity<BR>Falk Hiepe, Tobias Alexander, and Andreas Radbruch</P><P>Ch 4 CAR T cells for Autoimmunity<BR>Michael C. Milone</P><P>Ch 5 Regulatory T cells for the treatment of autoimmune diseases<BR>Claudia Selck and Margarita Dominguez-Villar</P><P>Ch 6 Mesenchymal Stromal Cells Derived Extracellular Vesicles<BR>Inés Colmegna and Janusz Rak</P><P>Section 2

Biology of Stem Cells</P><P>Ch 7 Induced Pluripotent Stem Cells: the story of genetic reprogramming<BR>Richard K Burt</P><P>Ch 8 Mesenchymal stromal cell biology and clinical application<BR>Séverine Loisel & Karin Tarte</P><P>Ch 9 Neural Stem Cell Biology<BR>Angela Genchi, Beatrice von Wunster, Paola Panina-Bordignon and Gianvito Martino</P><P>Ch 10 Hematopoietic stem cells: Hierarchical versus Continuum<BR>Peter Quesenberry, Sicheng Wen, Laura Goldberg and Mark Dooner</P><P>Ch 11 Biology of Umbilical Cord Blood Cells<BR>Gesine Kogler and Stefanie Liedtke</P><P>Section 3

Regulatory requirements<BR>Ch 12 Quality, Accreditation, and Regulation in HSCT and Cellular Therapy for Autoimmune Diseases<BR>Eoin McGrath, Joseph Schwartz, Phyllis I. Warkentin, Riccardo Saccardi, John A. Snowden</P><P>Ch 13 EUROPEAN PERSPECTIVE ON CELLULAR THERAPY: GOOD TISSUE PRACTICE (GTP) VERSUS GOOD MANUFACTURING PRACTICE (GMP).<BR>Elodie Kerjean, Bechara Mfarrej, & Christian Chabannon</P><P>Ch 14 GMP Facility Requirements in the United States of America<BR>Cheryl Stratton and Ann LeFever</P><P>Section 4

Mesenchymal Stem Cells for Immune Diseases</P><P>Ch 15 Mesenchymal stromal cell therapy for acute graft versus host disease

from bench to clinical approval<BR>Erik Boberg and Katarina Le Blanc</P><P>Ch 16 Adipose-Derived Stem Cells for Systemic Sclerosis Digital Ulcers<BR>Nicoletta Del Papa, Antonina Minniti, Francesca Pignataro, Wanda Maglione and Roberto F. Caporali</P><P>Ch 17 Musculoskeletal stromal/progenitor cells-based cell therapy for Rheumatoid Arthritis (RA)<BR>Yves-Marie PERS, Dominique Farge and Christian Jorgensen</P><P>Ch 18 Mesenchymal Stromal cells for Systemic Sclerosis<BR>Dominique Farge</P><P>Ch 19 Mesenchymal stem cells (MSC) for systemic lupus erythematosus (SLE)<BR>Lingyun Sun and Xinran Yuan</P><P>Ch 20 Mesenchymal stem/stromal cells for multiple sclerosis and other neurological diseases<BR>Antonio Uccelli, Tiziana Vigo and Alice Laroni</P><P>Ch 21 Mesenchymal stromal cells for perianal fistulizing crohn's disease<BR>Antonio Giordano and Julián Panés</P><P>Ch 22 Umbilical Cord Blood or Mesenchymal Stromal Cells as Potential Therapies for Autism Spectrum Disorder<BR>Jessica M. Sun and Joanne Kurtzberg</P><P>Section 5

General concepts: HSCT for Autoimmune Diseases</P><P>Ch 23 Animal models of bone marrow transplantation for autoimmune diseases<BR>Yasushi Adachi, Ming Li, Richard K. Burt, Naoki Hosaka, Susumu Ikehara</P><P>Ch 24 Autologous HSCT conditioning regimens for autoimmune diseases<BR>Richard K Burt, Dominique Farge, Riccardo Saccardi, Kathleen Quigley, Xiaoqiang Han and John A. Snowden</P><P>Ch 25 Immune reconstitution after hematopoietic stem cell transplantation in autoimmune disease<BR>Paolo A. Muraro and Maria T. Cencion</P><P>Ch 26 Microbiota and immune response<BR>Ernst Holler, Hendrik Poeck, and Daniela Weber</P><P>Ch 27 Infectious complications in patients undergoing HSCT for autoimmune diseases.<BR>Richard K Burt and Dominique Farge</P><P>Ch 28 Early Toxicity and Supportive Care of HSCT for Autoimmune Diseases<BR>John A Snowden, Azza Ismail, Richard K Burt, Helen Jessop</P><P>Ch 29 Late toxicity and supportive care of patients undergoing haematopoietic cell transplantation for autoimmune diseases<BR>Nina Salooja, Richard K Burt and John A. Snowden</P><P>Ch 30 Transfusion Medicine<BR>Khaled El-Ghariani</P><P>Ch 31 International Registries Sites / Indications / Activity for HSCT in Autoimmune Diseases: the European Society for Blood and Marrow Transplantation (EBMT) and Center for International Blood and Marrow Transplant Research (CIBMTR)<BR>John A. Snowden, Raffaella Greco, Manuela Badoglio, Myriam Labopin, Omar F. Dávila Alvelo and Marcelo C. Pasquini</P><P>Ch 32 Hematopoietic stem cell mobilization, collection, apheresis, and harvest procedures<BR>Emilian Snarski and Richard K Burt</P><P><BR>Section 6

Allogeneic HSCT for Autoimmune disease<BR>Ch 33 Hematopoietic Stem Cell Donor Registries: Search Strategies and HLA Methodologies<BR>Catherine Stavropoulos-Giokas, Vasiliki Gkioka and Dominique Charron</P><P>Ch 34 Allogeneic HSCT and Graft-versus-Host Disease (GvHD): general principles with reference to autoimmune diseases<BR>Jose Ros-Soto, Richard K Burt and John A. Snowden</P><P>Ch 35 Haematopoietic cell transplantation in monogenic autoimmune diseases<BR>Su Han Lum, Emilie P Buddingh, Mary A Slatter and Arjan C Lankester</P><P>Ch 36 Advances In The Pathogenesis And Treatment Of Immune Mediated Aplastic Anemia<BR>Shinji Nakao, Sabrina Giammarco and Andrea Bacigalupo</P><P>Section 7- HSCT for autoimmune disease Multiple Sclerosis</P><P>Ch 37 Magnetic Resonance Imaging in Multiple Sclerosis<BR>Flavia Nelson</P><P>Ch 38 Multiple Sclerosis <BR>Azza Ismail, Richard K Burt, Joachim Burman, Basil Sharrack</P><P>Ch 39 Disease-modifying therapies and supportive care of multiple sclerosis<BR>Edith Graham, Eileah Loda, and Roumen Balabano</P><P>Ch 40 Autologous hematopoietic stem cell transplantation for Secondary Progressive Multiple Sclerosis<BR>Richard K Burt, Basil Sharrack, Roumen Balabanov, John Rose, Xiaoqiang Han, Kathleen Quigley and Riccardo Saccardi </P><P>Ch 41 Autologous hematopoietic stem cell transplantation for Relapsing Remitting Multiple Sclerosis<BR>Richard K Burt, Basil Sharack, Joachim Burman, Flavia Nelson, John Rose, Xiaoqiang Han, Kathleen Quigley and Riccardo Saccardi</P><P>Ch 42 Immune mechanisms of autologous hematopoietic stem cell transplantation for multiple sclerosis<BR>Joachim Burman</P><P><BR>Chronic Inflammatory Demyelinating Polyradiculoneuropathy </P><P>Ch 43 Basics and interpretation of electrodiagnostic testing<BR>Hamza Malek</P><P>Ch 44 Diagnosis and Differentiation of CIDP from other peripheral polyneuropathies<BR>Céline Labeyrie Fanny Urbain and Cristina Castilla Llorente</P><P>Ch 45 Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy<BR>Gavin Brittain, Richard K Burt, Basil Sharrack</P><P>Neuromyelitis Optica</P><P>Ch 46 Autologous and Allogeneic HSCT for AQP4-IgG positive Neuromyelitis Optica Spectrum Disorders<BR>Raffaella Greco, Shailee Shah, Sean J Pittock and Richard K Burt</P><P><BR>Systemic Sclerosis</P><P>Ch 47 Systemic Sclerosis<BR>Katja Lakota, Katja Perdan Pirkmajer and John Varga</P><P>Ch 48 The Systemic Sclerosis Heart<BR>Sanjiv J. Shah</P><P>Ch 49 Scleroderma Renal Crisis with special considerations for Autologous Hematopoietic Stem Cell Transplant<BR>Marie Hudson, Harold L.

Atkins and Cybele Ghossein</P><P>Ch 50 Systemic Sclerosis and the Lung<BR>David G Kiely and Robin Condliffe</P><P>Ch 51 AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SYSTEMIC SCLEROSIS<BR>Dominique Farge, Zora Marjanovic, Richard K Burt</P><P>Crohn Disease<BR>Ch 52 Crohn's Disease: Incidence, Diagnosis, Standard Treatment, Prognosis, Outcome Measures<BR>Gabriel Marcellier MD, Xavier Treton</P><P>Ch 53 Hematopoietic Stem cell transplantation an alternative to treat Crohn's disease<BR>Milton Artur Ruiz, Montserrat Rovira, Elena Ricart, Roberto Luiz Kaiser Junior, Richard K Burt </P><P>Type I Diabetes Mellitus</P><P>Ch 54 Hematopoietic Stem Cell Transplantation for Type I Diabetes Mellitus<BR>Carlos Eduardo Couri and Maria Carolina Oliveira</P><P>Systemic Lupus Erythematosus</P><P>Ch 55 Hematopoietic stem cell transplantation for systemic lupus erythematosus (SLE)<BR>Tobias Alexander, Renate Arnold, Falk Hiepe, and Richard K Burt</P><P>Celiac Disease</P><P>Ch 56 Hematopoietic Stem Cell Transplantation for Refractory Celiac Disease type II<BR>Abdulbaqi Al-Toma</P><P>Section 8

Developing indications for HSCT</P><P>Ch 57 Haematopoietic stem cell transplantation for Juvenile Idiopathic Arthritis<BR>Mario Abinun, Su Han Lum, Arina Lazareva, Paul Veys, Mary A Slatter</P><P>Ch 58 Haematopoietic Stem Cell Transplantation for Rheumatoid Arthritis<BR>Ross Penglase, Robert D Sandler, John Moore and John A. Snowden</P><P>Ch 59 Hematopoietic Stem Cell Transplantation for Behçet's Syndrom

Notes:

Electronic reproduction. London Available via World Wide Web.

Print version record.

Local Notes:

Acquired for the Penn Libraries with assistance from the William Pepper Medical Library Fund.

Other Format:

Print version: Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases.

ISBN:

9781315151366

1315151367

9781351364768

1351364766

Publisher Number:

99989757789

Access Restriction:

Restricted for use by site license.